In 1957, Maurice Raben successfully isolated and purified the growth hormone (GH) from the pituitary gland, opening up a potential avenue of GH therapies. Children who were born with a deficiency of this hormone could now ...
Mar 13, 2023
0
2
India's Health Ministry said Thursday it was examining charges that the government's top drug regulatory agency had colluded with pharmaceutical firms to approve drugs without proper clinical trials.
May 10, 2012
0
0
They say the real crisis stems from current incentives that reward companies for developing large numbers of new drugs with few clinical advantages over existing ones.
Aug 7, 2012
0
0
Drug companies spent $97.5 million marketing pharmaceuticals in the District of Columbia in 2012, with $30.5 million (31.3%) of that spending taking the form of payments and gifts to physicians, hospitals, and other healthcare ...
Mar 6, 2014
0
0
French drugmaker Sanofi said Friday that it had begun building a new manufacturing facility in Vietnam to serve the expanding pharmaceutical market in southeast Asia.
Mar 29, 2013
0
0
Drug companies spent nearly $84 million marketing pharmaceuticals in the District of Columbia in 2011, including an outlay of nearly $19 million for gifts given to physicians, hospitals and other health care providers, according ...
Mar 1, 2013
0
0
(HealthDay)—Social and population variations in mental diagnosis are not accounted for in the newly revised fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), according to an editorial published ...
May 14, 2013
1
0
A lawsuit says representatives of some of the nation's largest generic drug manufacturers used code words to collude with competitors to divvy up market share and coordinate price increases.
Jun 24, 2019
0
0
The manner in which pharmaceutical companies market their products to people who have hemophilia appears unprecedented and direct-to-consumer marketing should be examined by regulators, say researchers who reviewed documents, ...
Jun 14, 2016
0
0
India's Health Ministry said Friday it had set up an expert panel to review the operations of its drug regulatory agency, accused of colluding with pharmaceutical firms to approve drugs without trials.
May 11, 2012
0
0
